APA (7th ed.) Citation

DF, B., J, A., M, F., HJ, C., K, K., E, D., . . . D, M. (2025). Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum Chemotherapy. Journal of medicinal chemistry, 68(22), 24294. https://doi.org/10.1021/acs.jmedchem.5c02196

Chicago Style (17th ed.) Citation

DF, Beirne, et al. "Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity Against Renal Cell Carcinoma When Compared to Conventional Platinum Chemotherapy." Journal of Medicinal Chemistry 68, no. 22 (2025): 24294. https://doi.org/10.1021/acs.jmedchem.5c02196.

MLA (9th ed.) Citation

DF, Beirne, et al. "Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity Against Renal Cell Carcinoma When Compared to Conventional Platinum Chemotherapy." Journal of Medicinal Chemistry, vol. 68, no. 22, 2025, p. 24294, https://doi.org/10.1021/acs.jmedchem.5c02196.